Life Force
Natural health product licensed in Canada
- Licence holder
- Aperture Energetics Inc.
- NPN or DIN-HM
- 80036862
- Status
- Active licence
- Licence date
- 25 October 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Brassica oleracea var. botrytis Source : Florets | 50 mg | Not calculated |
| Ginkgo biloba Source : Feuille | 10 mg | Not calculated |
| Eleutherococcus senticosus Source : Racine | 125 mg | Not calculated |
| Taraxacum officinale Source : Feuille | 10 mg | Not calculated |
| Oryza sativa Source : Enveloppe | 1,000 mg | Not calculated |
| Palmaria palmata Source : Feuille | 25 mg | Not calculated |
| Malus domestica Source : Fruit fibre | 500 mg | Not calculated |
| Rehmannia glutinosa Source : Racine | 125 mg | Not calculated |
| myo-Inositol-hexakisphosphate 3-phosphohydrolase Source : Aspergillus niger - En entier | 0.57 mg | Not calculated |
| myo-Inositol-hexakisphosphate 3-phosphohydrolase Source : Aspergillus niger - En entier | 0.046 FCC FTU | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger - En entier | 0.57 mg | Not calculated |
| Salvia officinalis Source : Feuille | 10 mg | Not calculated |
| Diastase du malt Source : Hordeum vulgare | 0.17 mg | Not calculated |
| Diastase du malt Source : Hordeum vulgare | 5.17 FCC DP | Not calculated |
| Diastase du malt Source : En entier | 0.17 mg | Not calculated |
| Diastase du malt Source : En entier | 5.17 FCC DP | Not calculated |
| Curcuma longa Source : Rhizome | 10 mg | Not calculated |
| Thymus vulgaris Source : Feuille | 10 mg | Not calculated |
| Ipomoea batatas Source : Tubercule | 50 mg | Not calculated |
| Beta vulgaris Source : Racine | 500 mg | Not calculated |
| Malpighia glabra Source : Cerise | 100 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Cellulose, microcristalline, Stéarate de magnésium, Silice, Saveur
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides antioxidants for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80036862
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.